
Signs and Symptoms of Myasthenia Gravis
The onset of myasthenia gravis (MG) may be sudden and oftentimes difficult to diagnose as the symptoms aren’t immediately recognized as myasthenia gravis.
Obtenga asistencia para el copago de IgIV
Habla con un especialistaMyasthenia gravis may affect the voluntary muscles in our bodies. These muscles are responsible for controlling eye and eyelid movement, facial expression, and swallowing. In most cases, initial noticeable symptoms include weakness of the eye muscles, difficulty in swallowing, and slurred speech. However, the degree of muscle weakness involved in myasthenia gravis varies greatly among patients.
Depending on the type and severity, the symptoms may include a drooping of one or both eyelids (ptosis); blurred or double vision (diplopia) due to weakness of the muscles that control eye movements; unstable or waddling gait; weakness in arms, hands, fingers, legs, and neck; a change in facial expression; difficulty in swallowing and shortness of breath; and impaired speech (dysarthria).
¿Puede ayudar la IgIV?
Información gratuita sobre el tratamiento con IgIVComplications of Myasthenia Gravis
Myasthenic Crisis
Myasthenic crisis is a potentially life-threatening complication of MG. About one in five people with MG may develop myasthenic crisis at least once in their lifetime. It occurs when your respiratory muscles become too weak to support breathing. If left untreated, a myasthenic crisis can result in respiratory failure and death.
REFERENCIAS:
- https://www.mda.org/disease/myasthenia-gravis
- Basta, Ivana et al. “Supervivencia y mortalidad de la miastenia gravis de inicio en la edad adulta en la población de Belgrado, Serbia”. Muscle & nerve vol. 58,5 (2018): 708-712. doi:10.1002/mus.26132.
- Christensen PB, Jensen TS, Tsiropoulos I, y otros Mortalidad y supervivencia en la miastenia gravis: un estudio poblacional danés, Journal of Neurology, Neurosurgery & Psychiatry 1998;64:78-83.
- Alshekhlee, A et al. “Tasas de incidencia y mortalidad de la miastenia gravis y la crisis miasténica en hospitales estadounidenses”. Neurología, vol. 72, 18 (2009): 1548-54. doi:10.1212/WNL.0b013e3181a41211.
- Wendell, Linda C. y Joshua M. Levine. “Crisis miasténica”. The Neurohospitalist, vol. 1, 1 (2011): 16-22. doi:10.1177/1941875210382918.
- Twork, S., Wiesmeth, S., Klewer, J. et al. Calidad de vida y circunstancias vitales en pacientes alemanes con miastenia gravis. Health Qual Life Outcomes 8, 129 (2010). https://doi.org/10.1186/1477-7525-8-129.
- Szczudlik, Piotr et al. “Determinantes de la calidad de vida en pacientes con miastenia grave”. Frontiers in Neurology, vol. 11, 553626. 23 de septiembre de 2020, doi:10.3389/fneur.2020.553626.